Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Decompensated Heart Failure: later-stage trial registry

2 of 3 indexed Decompensated Heart Failure trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Decompensated Heart Failure: 3 US clinical trials tracked, 2 recruiting.

Decompensated Heart Failure is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Florida International University, running 1 of these trials.

Enrollment posture brief

Registry condition decompensated-heart-failure

OPEN 2 | RECR 67% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Decompensated Heart Fail (th…67%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Decompensated Heart Failure

Decompensated Heart Failure lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Decompensated Heart Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Decompensated Heart Failure is recruiting above its size-band peers.

    2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Decompensated Heart Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Control/Placebo group Drug
1 trials
Point-of-Care Ultrasound (POCUS) Device
1 trials
Colchicine 0.6 mg Drug
1 trials

US sites by state

Facility locations filed on Decompensated Heart Failure trials. A trial with sites in several states counts in each.

Virginia 1 trials
Michigan 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Decompensated Heart Failure page

3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Decompensated Heart Failure condition card totals 3 registered trials; most-linked intervention Control/Placebo group; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.